Biologics

Amylase or maltose to treat or prevent neurodegeneration (SJ-20-0009)

Anti-GD2-BB-zeta chimeric receptor (SJ-13-0035)

Antibodies to Tim4 for use as an immune enhancer and cancer therapeutic (SJ-18-0006)

Association of neuraminidase regulated exocytosis with cancer metastasis (SJ-11-0012)

B7-H3-CAR 41BB ligand co-stimulation for solid tumors (SJ-19-0014)

BCRP/ABCG2 as Stem Cell Marker (SJ-97-0016)

CD123 CARs with a CD20 safety switch for treatment of AML (SJ-19-0025)

CD33 CAR (SJ-17-0010)

CD7 CAR placed in CD7neg memory cells (SJ-15-0020)

Chimeric IL13-MyD88 and PDL1-MyD88 receptors (SJ-20-0032)

Chimeric gene and protein generated Optogranules: Light induced stress granules (SJ-18-0010)

Combination DNMT3a KO and IL10 signaling (SJ-21-0018)

DNA methylation profile and biomarkers to identify functional T-cells (SJ-17-0002)

DNMT3a knockout CAR T cells with Antigen Specificity (for solid tumors) (SJ-19-0024)

Development and optimization of a serotype-independent method of adeno-associated virus (AAV) harvest and purification (SJ-16-0036)

Differentiating T-cells (SJ-18-0019)

Erythroid Specific Promoter for Hematopoietic Disorders (SJ-16-0040)

Ets1 and Rbpj Knock-Outs to Improve T Cell Function (SJ-24-0015)

Extradomain-B fibronectin (EDB)-targeted CAR immune cell therapy (SJ-19-0029)

Fibcd1 to treat or prevent muscle wasting (SJ-20-0008)

GMCSF.IL18 chimeric cytokine receptor for solid tumors (SJ-19-0028)

GRP78 and CD123 targeted adoptive cell therapy for cancer (SJ-22-0021)

GRP78 targeted adoptive cell therapy for surface GRP78+ (pediatrics and adult) cancer (SJ-19-0050)

Gene Responsible for Social Memory in Schizophrenia (SJ-19-0048)

Gene Therapy Vector Insulator Elements (SJ-20-0026)

Gene Therapy for Wiskott-Aldrich Syndrome (SJ-19-0012)

Generation of therapeutic T cell receptors for fibrolamellar cancer (SJ-19-0046)

HMGA2 in gene therapy vectors (SJ-16-0014)

Hybrid compounds to treat gastrointestinal infections (SJ-14-0019/UTA 14-01)

IL13 promoter to express therapeutic genes (SJ-18-0042)

IL35 receptor (SJ-08-0039)

Immune cells with DNMT3A gene modifications (SJ-16-0009)

Immunotherapy with Glutamine to Treat Cancer (SJ-23-0010)

Improved GD2 Ab for neuroblastoma (SJ-17-0017)

Improvement producing proteins to treat lysosomal storage disorders (SJ-01-0020)

Improving HSC engraftment by inhibiting GASP genes (SJ-16-0029)

Inhibiting ASXL1 to improve T cell Immunotherapy (SJ-22-0034)

Inhibiting Mir-451 to treat Beta-Thalassemia (SJ-20-0030)

Inhibition of eIF4A to improve T cell efficacy (SJ-22-0012)

Interleukin-35 (IL-35) (SJ-06-0016)

MAGE-A11 inhibitor for cancer (SJ-20-0033)

MRT67307 treatments for enhancing NK cells (SJ-21-0020)

Method for Enhancing Recombinant Antibody Production (SJ-08-0032)

Method to Activate Fetal Hemoglobin Expression (SJ-20-0020)

Minimized Liver Specific Promoter to Improve Gene Therapy Vectors (SJ-04-0024)

Modulating Regulatory T Cells By Targeting Foxp3 Enhancers (SJ-22-0010)

Myd88 and CD40 costimulatory domains for chimeric antigen receptors (SJ-18-0021)

Neuropiln 1 (Nrp1) modulation for immune system control (SJ-13-0012)

Predicting T-cell development stage (and therapy success) (SJ-19-0033)

Primer Panel for T cell receptor amplification (SJ-21-0039)

Primer generation of T-Cell Receptor (TCR) sequences for immune response (SJ-19-0017)

Promoter Modification to Reduce AAV Contamination (SJ-19-0003, SJ-23-0028)

Protease Serine 21 (PRSS21) targeted immunotherapies (SJ-18-0043)

REGNASE-1 gene knockout or BATF overexpression for improving T-cells (SJ-19-0027, SJ-20-0007)

RIPK3 fusion protein for cancer and autoimmunity (SJ-12-0036)

Rapid cloning of T cell receptors (SJ-16-0001)

Regulating p53 translation and function (SJ-05-0002)

SJ293TS cell line (SJ-19-0054)

SJ293TS-DPB Cells for Lentiviral Vector Production (SJ-24-0024)

Safety test for gene therapy vectors (SJ-15-0027)

Selecting and modifying CD7 Cells (SJ-20-0012)

Signatures associated with highly functional CAR T cells (SJ-22-0008)

T-cell Aging Biomarker (SJ-23-0009)

TNC and COL11A1 CARs (SJ-21-0009)

Ulk1-/- Ulk2 flox/- hypomorph mice and cell lines (SJ-19-0004)

Universal Chimeric Receptor for T-Cell Therapy (SJ-13-0031)

Universal Synapse Enhancing Domain (PDZbm) (SJ-22-0011)

VIPR1 modulators for improving auditory capabilities (SJ-22-0023)

Zip Cytokine Receptor CARs (SJ-22-0002, SJ-23-0024)

cBAF Inhibitors for Improving T Cell Immunotherapy (SJ-22-0015)

miRNAs for treating cerebral ventricle enlargement in schizophrenia patients (SJ-19-0039)

p53 inhibitory oligonucloeotides (SJ-09-0015)

Biologics

For more information

More Technologies